Related Experiment Video
Updated: Sep 13, 2025

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
Published on: February 2, 2021
Risk-Stratified Prognostic Implications of Contrast-Associated Acute Kidney Injury After Percutaneous Coronary
Takahiro Suzuki1, Shun Kohsaka2, John A Spertus3
1Department of Cardiology, Keio University School of Medicine, Tokyo, Japan; Department of Cardiovascular Medicine, St. Luke's International Hospital, Tokyo, Japan.
Insights
Contrast-associated acute kidney injury (CA-AKI) after percutaneous coronary intervention (PCI) is linked to worse long-term outcomes across all patient risk levels. This highlights the need for strategies to prevent CA-AKI during PCI procedures.
Area of Science:
- Cardiology
- Nephrology
- Interventional Cardiology
Background:
- Contrast-associated acute kidney injury (CA-AKI) is a common complication following percutaneous coronary intervention (PCI).
- The clinical significance of CA-AKI and its impact on long-term patient outcomes remain subjects of debate.
- Assessing CA-AKI's association with long-term adverse events is crucial for risk stratification and management.
Purpose of the Study:
- To evaluate the association between CA-AKI and major adverse cardiovascular events (MACE) up to two years post-PCI.
- To analyze this association across different pre-procedural risk categories defined by the National Cardiovascular Data Registry (NCDR) AKI risk score.
- To determine if pre-procedural risk modifies the impact of CA-AKI on long-term outcomes.
Main Methods:
- Analysis of a Japanese registry of 7,916 patients undergoing PCI from September 2008 to October 2021.
- Patients were stratified into low, intermediate, and high-risk groups based on NCDR AKI risk score tertiles.
- CA-AKI was defined by creatinine increase or dialysis initiation; 2-year MACE was assessed using Cox regression.
Main Results:
- CA-AKI developed in 9.1% of patients, with incidence rates of 2.3% (low-risk), 7.3% (intermediate-risk), and 17.9% (high-risk).
- CA-AKI was significantly associated with an increased risk of 2-year MACE (aHR: 1.64).
- This association was consistent across all risk categories (low-risk aHR: 2.84; intermediate-risk aHR: 1.64; high-risk aHR: 1.60), with no significant interaction effect.
Conclusions:
- CA-AKI is associated with adverse long-term cardiovascular outcomes in patients undergoing PCI, irrespective of their baseline risk profile.
- These findings emphasize the importance of implementing preventive measures to reduce the incidence of CA-AKI.
- Proactive strategies to mitigate CA-AKI are essential for improving patient prognosis after PCI.
Background:
The clinical importance of contrast-associated acute kidney injury (CA-AKI), the most common complication after percutaneous coronary intervention (PCI), is debated.
Objectives:
We aimed to assess the association between CA-AKI and long-term outcomes, overall and across the National Cardiovascular Data Registry (NCDR) AKI risk categories.
Methods:
We analyzed patients undergoing PCI between September 2008 and October 2021 from a Japanese registry aligned with the NCDR and categorized them by the NCDR AKI risk score tertiles (low-risk [<4.9%], intermediate-risk [4.9%-6.7%], and high-risk [≥6.7%]) groups. CA-AKI was defined as a 0.3 mg/dL increase or 50% increase in creatinine or the initiation of dialysis. Cox regression analyses assessed the association between CA-AKI and 2-year major adverse cardiovascular events (MACE; all-cause mortality, acute coronary syndrome, heart failure hospitalization, or stroke), and interactions were tested to examine whether preprocedural risk modified the association of CA-AKI with outcomes.
Results:
Of 7,916 patients, 723 (9.1%) developed CA-AKI; its incidence for low-risk, intermediate-risk, and high-risk groups was 2.3%, 7.3%, and 17.9%, respectively. CA-AKI was associated with an increased risk of MACE (adjusted HR [aHR]: 1.64; 95% CI: 1.37-1.97). The interaction between AKI risk profile and MACE was not significant (P interaction = 0.14), and a consistent association of CA-AKI and MACE across risk categories was observed (high-risk, aHR: 1.60; 95% CI: 1.30-1.98; intermediate, aHR: 1.64; 95% CI: 1.10-2.44; and low, aHR: 2.84; 95% CI: 1.43-5.65, respectively).
Conclusions:
CA-AKI was associated with long-term outcomes across all AKI risk profiles in PCI patients, underscoring the importance of interventions to reduce periprocedural CA-AKI.
More Related Videos
Related Concept Videos
Cardiac Catheterization I: Pre-Procedure Overview
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury III: Clinical Manifestations

